Ann Arbor, Mich.; Hanover, N.H.; Birmingham, Ala.; Madison, Wis.; Chicago, Ill.; Seattle, Wash.; and Evanston, Ill. From the Section of Plastic Surgery, Department of Surgery, The University of Michigan Medical Center; Department of Surgery, Dartmouth Medical School; Department of General Surgery, St. Joseph Mercy Hospital; Division of Plastic Surgery, The University of Alabama at Birmingham School of Medicine; The University of Wisconsin, Madison; Grotting Plastic Surgery; American Society of Plastic Surgeons; Department of Surgery, University of Washington; private practice; Division of Plastic Surgery, NorthShore University HealthSystem; and the University of Chicago.
Plast Reconstr Surg. 2009 Dec;124(6):2127-2133. doi: 10.1097/PRS.0b013e3181bf8378.
The authors evaluated the use of national databases to track surgical complications among abdominoplasty and breast augmentation patients.
Their study population included all patients with abdominoplasty or breast augmentation in the Tracking Operations and Outcomes for Plastic Surgeons (TOPS) and CosmetAssure databases from 2003 to 2007. They evaluated the incidence of hematoma, infection, and/or deep venous thrombosis/pulmonary embolism. Chi-square and t tests were used for the analyses.
The TOPS and CosmetAssure databases included 7310 and 3350 patients with abdominoplasty and 30,831 and 14,227 patients with breast augmentation, respectively. In the TOPS and CosmetAssure populations, the complication rates for abdominoplasty were 0.9 percent and 0.5 percent with hematoma (p = 0.29), 3.5 percent and 0.7 percent with infection (p < 0.001), and 0.3 percent and 0.1 percent with deep venous thrombosis/pulmonary embolism (p = 0.05), respectively. The complication rates for breast augmentation in TOPS and CosmetAssure were 0.6 percent and 0.7 percent with hematoma (p = 0.21), 0.3 percent and 0.1 percent with infection (p < 0.001), and 0.02 percent and less than 0.01 percent with deep venous thrombosis/pulmonary embolism (p = 0.31), respectively.
Complication rates for abdominoplasty and breast augmentation were similar in TOPS and CosmetAssure, providing a measure of cross-validation. The low complication rates support the safety of these procedures when they are performed by plastic surgeons. These data should be used by individual practitioners for outcomes benchmarking.
作者评估了使用国家数据库来跟踪腹部整形和隆胸患者的手术并发症。
他们的研究人群包括 2003 年至 2007 年在追踪整形外科医生手术和结果（TOPS）和 CosmetAssure 数据库中接受腹部整形或隆胸的所有患者。他们评估了血肿、感染和/或深静脉血栓形成/肺栓塞的发生率。使用卡方检验和 t 检验进行分析。
TOPS 和 CosmetAssure 数据库分别包括 7310 例和 3350 例腹部整形患者，以及 30831 例和 14227 例隆胸患者。在 TOPS 和 CosmetAssure 人群中，腹部整形术的并发症发生率为血肿 0.9%和 0.5%（p = 0.29），感染 3.5%和 0.7%（p < 0.001），深静脉血栓形成/肺栓塞 0.3%和 0.1%（p = 0.05）。TOPS 和 CosmetAssure 中隆胸术的并发症发生率为血肿 0.6%和 0.7%（p = 0.21），感染 0.3%和 0.1%（p < 0.001），深静脉血栓形成/肺栓塞 0.02%和小于 0.01%（p = 0.31）。
TOPS 和 CosmetAssure 中腹部整形和隆胸术的并发症发生率相似，提供了交叉验证的一种手段。这些低并发症发生率支持了整形外科医生进行这些手术的安全性。这些数据应被个体从业者用于结果基准测试。
